Acasti Pharma Inc. (ACST)
NASDAQ: ACST · IEX Real-Time Price · USD
3.037
+0.167 (5.82%)
Jul 22, 2024, 10:04 AM EDT - Market open
Acasti Pharma Employees
Acasti Pharma had 32 employees as of March 31, 2020. The number of employees increased by 4 or 14.29% compared to the previous year.
Employees
32
Change (1Y)
4
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$401,656
Market Cap
27.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2020 | 32 | 4 | 14.29% |
| Mar 31, 2019 | 28 | 17 | 154.55% |
| Feb 29, 2016 | 11 | 4 | 57.14% |
| Feb 28, 2015 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ATI Physical Therapy | 6,000 |
| Beyond Air | 107 |
| Renalytix | 102 |
| Bolt Biotherapeutics | 100 |
| Enlivex Therapeutics | 71 |
| SAB Biotherapeutics | 57 |
| Palatin Technologies | 34 |
| Brainstorm Cell Therapeutics | 29 |
ACST News
- 24 days ago - Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial - GlobeNewsWire
- 4 weeks ago - Acasti Announces Year-End 2024 Financial Results, Provides Business Update - GlobeNewsWire
- 7 weeks ago - Acasti Pharma to Attend BIO International Convention 2024 - GlobeNewsWire
- 5 months ago - Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 6 months ago - Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial - GlobeNewsWire
- 7 months ago - Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024 - GlobeNewsWire
- 9 months ago - Acasti Announces Second Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 9 months ago - Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial - GlobeNewsWire